Document:

Exhibit 4.8

       

      AMENDMENT N°1 TO RELATIONSHIP AGREEMENT

      

      

      BETWEEN THE UNDERSIGNED:

       

      	(1)	
              Technip Energies N.V., a public limited liability company incorporated under the laws of the Netherlands (the “Company”);

            

       

      	(2)	
              TechnipFMC plc, a public limited company formed under the laws of England and Wales (“TFMC”); and

            

       

      	(3)	
              Bpifrance Participations SA, a société anonyme incorporated under the laws of the Republic of France (“Shareholder”).

            

       

      The Company, TFMC and Shareholder are each referred to herein individually as a “Party” and collectively as the “Parties”.

       

      RECITALS:

       

      	A.	
              On January 7, 2021, TFMC and Shareholder entered into a share purchase agreement (the “Share Purchase Agreement”) relating to certain shares of the Company.

            

       

      	B.	
              On January 7, 2021, the Parties entered into a relationship agreement (the “Relationship Agreement”) relating to certain governance and other matters.

            

       

      	C.	
              On March 31, 2021, TFMC and Shareholder entered into an amendment to the Share Purchase Agreement, pursuant to which the Purchase Price (as defined in the Share Purchase Agreement) was reduced from $200,000,000 to $100,000,000, resulting
                in a number of Purchased Shares (as defined in the amendment to the Share Purchase Agreement) of 7,474,829.

            

       

      	D.	
              In view of the amendment to the Share Purchase Agreement, the Parties wish to amend certain provisions of the Relationship Agreement on the terms set forth herein, by entering into this amendment to the Relationship Agreement (the “Amendment”),

                with all such amendments to be effective as of April 20, 2021.

            

       

      NOW, THEREFORE, THE PARTIES AGREE AS FOLLOWS:

       

      

      
        Article I

        

      

      DEFINITIONS AND PRINCIPLES OF INTERPRETATION

       

      	 	1.1	
              Definitions

            

       

      Capitalized terms used but not defined herein shall have the meaning set forth in the Relationship Agreement.

       

      	

            	1.2	
              Principles of interpretation

            

       

      
        	 	
                (a)

              	
                The numbering of each article, section, paragraph, schedule, annex or exhibit of the Relationship Agreement shall not be affected by any of the amendments contained in the Amendment.

              

      

       

      

      
        1

        
          

      

      
        	 	
                (b)

              	
                Any reference to the “date hereof” in the Relationship Agreement shall be read as January 7, 2021.

              

      

       

      
        	 	
                (c)

              	
                From and after the date of this Amendment, any reference to the Relationship Agreement shall be deemed to be a reference to the Relationship Agreement as amended by this Amendment.

              

      

       

      

      Article II

      AMENDMENTS

       

      

      	

            	2.1	
              Amendments to Section 2.01 of the Relationship Agreement

            

       

      The Parties hereby agree to amend Section 2.01 of the Relationship Agreement (Composition of the Board; Nomination of the Non-Executive Directors) as follows with effect as of
        April 20, 2021:

       

      
        	 	
                (a)

              	
                The words in the first part of Section 2.01 “Effective as of the Distribution Date:” are hereby deleted.

              

      

       

      
        	 	
                (b)

              	
                Section 2.01 (a) of the Relationship Agreement is hereby deleted in its entirety and replaced with the following:

              

      

       

      
        
          “(a)    For so long as Shareholder and its Permitted Transferees Beneficially Own the applicable percentage of Ordinary Shares set forth in this sentence, Shareholder shall have the right to
            propose one or two nominees to the Board for appointment as non-executive directors (the “Investor Nominated Directors”) as follows: (i) two Investor Nominated Directors, so long as Shareholder Beneficially Owns at least 18% of the
            Ordinary Shares; and (ii) one Investor Nominated Director, so long as Shareholder Beneficially Owns at least 5% of the Ordinary Shares but less than 18% of the Ordinary Shares; provided, however, that notwithstanding the amount
            of Ordinary Shares Beneficially Owned by Shareholder and its Permitted Transferees, Shareholder shall be entitled to propose one Investor Nominated Director for appointment to the Board at any general or extraordinary general meeting of the
            Company at which directors are appointed occurring prior to a vote on the Company’s annual financial statements of the fiscal year following the year in which the Distribution Date occurs. ”

        

      

      

      

      
        
          
            	 	
                    (c)

                  	
                    Section 2.01(f)(iv) of the Relationship Agreement is hereby deleted in its entirety and replaced with the following:

                  

          

        

      

       

      
        
          
            	 	
                    “(iv)

                  	
                    the applicable number of Investor Nominated Director(s) pursuant to Section 2.01(a) above to be appointed.”

                  

          

        

      

       

      	

            	2.2	
              Amendment to Section 7.01 of the Relationship Agreement

            

       

      The Parties hereby agree to amend Section 7.01 of the Relationship Agreement as follows with effect as of April 20, 2021:

       

      The references to Schedule 7.01(ii) included in Section 7.01 of the Relationship Agreement are hereby deleted, and Schedule 7.01(ii) to the Relationship Agreement is hereby deleted in its entirety.

       

      

      
        2

        
          

      

      Article III

      MISCELLANEOUS

      

      

      	

            	3.1	
              No other amendment

            

       

      The Parties acknowledge and agree that all the provisions of the Relationship Agreement not expressly amended pursuant to this Amendment shall continue to be valid and binding on the Parties, in full force and
        effect, and shall not be deemed to have been amended, waived, deleted or affected in any manner whatsoever by this Amendment.

       

      	

            	3.2	
              Incorporation by reference

            

       

      The provisions of Section 8 of the Relationship Agreement (Miscellaneous) are incorporated herein by reference and shall apply to the terms and provisions of this Amendment
        and the Parties mutatis mutandis.

      

      

      [Signature Pages Follow.]

       

      

      
        3

        
          

      

      In witness whereof, each of the Parties has executed this Agreement as of May 6, 2021.

      

      

      	 	
              TECHNIP ENERGIES N.V.

            
	 	 	 
	 	
              By:

            	
              /s/ Arnaud Pieton

            
	 	
              Name:

            	
              Arnaud Pieton

            
	 	
              Title:

            	
              Chief Executive Officer

            

       

      

      
        [Signature Page to Amendment to the Relationship Agreement]

      

      
        
          

      

      In witness whereof, each of the Parties has executed this Agreement as of May 3, 2021.

       

      	 	
              TECHNIPFMC PLC

            
	 	 	 
	 	
              By:

            	
              /s/ Alf Melin

            
	 	
              Name:

            	
              Alf Melin

            
	 	
              Title:

            	
              Executive Vice President and Chief Financial Officer

            

       

        [Signature Page to Amendment to the Relationship Agreement]

        

      

      
        
          

      

      In witness whereof, each of the Parties has executed this Agreement as of May 5, 2021.

      

      

      	 	
              BPIFRANCE PARTICIPATIONS S.A.

            
	 	 	 
	 	
              By:

            	
              /s/ Arnaud Caudoux

            
	 	
              Name:

            	
              Arnaud Caudoux

            
	 	
              Title:

            	
              Deputy CEO (Directeur Général Adjoint)

            

      

      

      [Signature Page to Amendment to the Relationship Agreement]Exhibit 4.5

 

glenfarne
merger CORP.

 

DESCRIPTION OF SECURITIES

 

As of the date of the Annual
Report on Form 10-K for the year ended December 31, 2021 (the “Report”) of Glenfarne Merger Corp, a Delaware corporation (“we,”
“us,” “our” or “the company”), of which this exhibit forms a part, the Company had the following three
classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”):
(i) its units, consisting of one share of Class A common stock (as defined below) and one-third of one redeemable warrant (as defined
below), with each whole warrant entitling the holder thereof to purchase one share of Class A common stock (the “units”),
(ii) its Class A common stock, $0.0001 par value per share (“Class A common stock”), and (iii) its public warrants, with each
whole warrant exercisable for one share of Class A common stock for $11.50 per share (the “warrants”). Defined terms used
herein but not otherwise defined shall have the meaning ascribed to such terms in the Report.

 

Pursuant to the Company’s
amended and restated certificate of incorporation (the “Charter”), our authorized capital stock consists of 220,000,000 shares
of common stock, including 200,000,000 shares of Class A common stock, $0.0001 par value and 20,000,000 shares of Class B common
stock, $0.0001 par value (“Class B common stock”), and 1,000,000 shares of preferred stock, $0.0001 par value. The following
description summarizes the material terms of our capital stock and does not purport to be complete. It is subject to, and qualified in
its entirety by reference to, the Charter, our by-laws and our warrant agreement, each of which is incorporated by reference as an exhibit
to the Report.

 

Units

 

Each unit consists of one share
of Class A common stock and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase
one share of our Class A common stock at a price of $11.50 per share, subject to adjustment as described in the warrant agreement.
Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares of Class A common
stock.

 

Class A Common Stock

 

Stockholders of record are entitled to one vote
for each share held on all matters to be voted on by stockholders. Prior to our initial business combination, only holders of our founder
shares will have the right to vote on the appointment of directors. Holders of our public shares will not be entitled to vote on the appointment
of directors during such time. In addition, prior to the completion of an initial business combination, holders of a majority of our founder
shares may remove a member of the board of directors for any reason. These provisions of our amended and restated certificate of incorporation
may only be amended by approval of a majority of at least 90% of our Class B common stock voting in an annual meeting. With respect to
any other matter submitted to a vote of our stockholders, including any vote in connection with our initial business combination, except
as required by law, holders of our founder shares and holders of our public shares will vote together as a single class, with each share
entitling the holder to one vote. Unless specified in our amended and restated certificate of incorporation, or as required by applicable
provisions of the DGCL or applicable stock exchange rules, the affirmative vote of a majority of our shares of common stock that are voted
is required to approve any such matter voted on by our stockholders. Our board of directors is divided into three classes, each of which
will generally serve for a term of three years with only one class of directors being elected in each year. There is no cumulative voting
with respect to the election of directors, with the result that the holders of more than 50% of the shares voted for the election of directors
can elect all of the directors. Our stockholders are entitled to receive ratable dividends when, as and if declared by the board of directors
out of funds legally available therefor.

 

Because our amended and restated certificate of
incorporation authorizes the issuance of up to 200,000,000 shares of our Class A common stock, if we were to enter into a business
combination, we may (depending on the terms of such a business combination) be required to increase the number of shares of our Class
A common stock which we will be authorized to issue at the same time as our stockholders vote on the business combination to the extent
we seek stockholder approval in connection with our initial business combination.

 

Our board of directors is divided into three classes
with only one class of directors being elected in each year and each class (except for those directors appointed prior to our first annual
meeting of stockholders) serving a three-year term. In accordance with the Nasdaq corporate governance requirements, we are not required
to hold an annual meeting until one year after our first fiscal year end following our listing on Nasdaq. Under Section 211(b) of the
DGCL, we are, however, required to hold annual meetings of stockholders for the purpose of electing directors in accordance with our amended
and restated bylaws, unless such election is made by written consent in lieu of such a meeting. We may not hold an annual meeting of stockholders
to elect new directors prior to the completion of our initial business combination, and thus we may not be in compliance with Section
211(b) of the DGCL, which requires an annual meeting. Therefore, if our stockholders want us to hold an annual meeting prior to the completion
of an initial business combination, they may attempt to force us to hold one by submitting an application to the Delaware Court of Chancery
in accordance with Section 211(c) of the DGCL. Prior to the completion of an initial business combination, any vacancy on the board of
directors may be filled by a nominee chosen by holders of a majority of our founder shares. In addition, prior to the completion of an
initial business combination, holders of a majority of our founder shares may remove a member of the board of directors for any reason.

 

     

     

    

 

We will provide our public stockholders with the
opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination at a per-share price,
payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the completion
of our initial business combination, including interest earned on the funds held in the trust account and not previously released to us
to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then outstanding public
shares, subject to the limitations described herein. The amount in the trust account is initially anticipated to be $10.00 per public
share. The per-share amount we will distribute to investors who properly redeem their shares will not be reduced by the deferred
underwriting commissions we will pay to the underwriters. The redemption rights will include the requirement that a beneficial owner must
identify itself in order to validly redeem its shares. Our sponsor and each member of our management team have entered into a letter agreement
with us, pursuant to which they have agreed to waive their redemption rights with respect to their founder shares and public shares in
connection with (i) the completion of our initial business combination and (ii) a stockholder vote to approve an amendment to our amended
and restated certificate of incorporation that would affect the substance or timing of our obligation to allow redemption in connection
with our initial business combination or to redeem 100% of our public shares if we have not completed an initial business combination
within 24 months from the closing of the initial public offering. Unlike many blank check companies that hold stockholder votes and
conduct proxy solicitations in conjunction with their initial business combinations and provide for related redemptions of public shares
for cash upon completion of such initial business combinations even when a vote is not required by law, if a stockholder vote is not required
by law and we do not decide to hold a stockholder vote for business or other reasons, we will, pursuant to our amended and restated certificate
of incorporation, conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior
to completing our initial business combination. Our amended and restated certificate of incorporation require these tender offer documents
to contain substantially the same financial and other information about the initial business combination and the redemption rights as
is required under the SEC’s proxy rules. If, however, a stockholder approval of the transaction is required by law, or we decide
to obtain stockholder approval for business or other reasons, we will, like many blank check companies, offer to redeem shares in conjunction
with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If we seek stockholder approval, we
will complete our initial business combination only if a majority of the shares of common stock voted are voted in favor of our initial
business combination. However, the participation of our sponsor, officers, directors, advisors or their affiliates in privately-negotiated transactions
(as described in the Report), if any, could result in the approval of our initial business combination even if a majority of our public
stockholders vote, or indicate their intention to vote, against such initial business combination. For purposes of seeking approval of
the majority of our outstanding common stock, non-votes will have no effect on the approval of our initial business combination once
a quorum is obtained.

 

We may, at our option, pursue a business combination
opportunity jointly with one or more entities affiliated with Glenfarne and/or one or more investors in funds or separate accounts managed
by Glenfarne, which we refer to as an “Affiliated Joint Acquisition.” Any such parties would co-invest only if (i) permitted
by applicable regulatory and other legal limitations; (ii) we and Glenfarne considered such a transaction to be mutually beneficial to
us as well as the affiliated entity; and (iii) other business reasons exist to do so, such as the strategic merits of including such co-investors,
the need for additional capital beyond the amount held in our trust account to fund the business combination transaction and/or the desire
to obtain committed capital for closing the business combination transaction. An Affiliated Joint Acquisition may be effected through
a co-investment with us in the target business at the time of our initial business combination, or we could raise additional proceeds
to complete the business combination by issuing to such parties a class of equity or equity-linked securities. We refer to this potential
future issuance, or a similar issuance to other specified purchasers, as a “specified future issuance” throughout the Report.
The amount and other terms and conditions of any such specified future issuance would be determined at the time thereof. We are not obligated
to make any specified future issuance and may determine not to do so. This is not an offer for any specified future issuance. Pursuant
to the anti-dilution provisions of our Class B common stock, any such specified future issuance (other than the forward purchase
securities) would result in an adjustment to the conversion ratio such that our initial stockholders and their permitted transferees,
if any, would retain their aggregate percentage ownership at 20% of the sum of the total number of all shares of common stock outstanding
upon completion of the initial public offering plus all shares issued in the specified future issuance (excluding the forward purchase
securities and any shares or equity-linked securities issued, or to be issued, to any seller in the business combination), unless
the holders of a majority of the then-outstanding shares of Class B common stock agreed to waive such adjustment with respect to
the specified future issuance at the time thereof. We cannot determine at this time whether a majority of the holders of our Class B common
stock would then agree to so waive such adjustment to the conversion ratio. They may waive such adjustment due to (but not limited to)
the following: (i) closing conditions which are part of the agreement for our initial business combination; (ii) negotiation with Class
A stockholders on structuring an initial business combination; (iii) negotiation with parties providing financing which would trigger
the anti- dilution provisions of the Class B common stock; or (iv) as part of the Affiliated Joint Acquisition. If such adjustment is
not waived, the specified future issuance would not reduce the percentage ownership of holders of our Class B common stock but would reduce
the percentage ownership of holders of our Class A common stock. If such adjustment is waived, the specified future issuance would reduce
the percentage ownership of holders of both classes of our common stock.

 

    2

     

    

 

If we seek stockholder approval of our initial business
combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules,
our amended and restated certificate of incorporation provides that a public stockholder, together with any affiliate of such stockholder
or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange
Act), will be restricted from seeking redemption rights with respect to more than an aggregate of 15% of the shares sold in the initial
public offering without our prior consent, which we refer to as the “Excess Shares.” However, we would not be restricting
our stockholders’ ability to vote all of their shares (including Excess Shares) for or against our initial business combination.
Our stockholders’ inability to redeem the Excess Shares will reduce their influence over our ability to complete our initial business
combination, and such stockholders could suffer a material loss in their investment if they sell such Excess Shares on the open market.
Additionally, such stockholders will not receive redemption distributions with respect to the Excess Shares if we complete our initial
business combination. And, as a result, such stockholders will continue to hold that number of shares exceeding 15% and, in order to dispose
such shares would be required to sell their shares in open market transactions, potentially at a loss.

 

If we seek stockholder approval in connection with
our initial business combination, pursuant to the terms of a letter agreement entered into with us, our sponsor and each member of our
management team have agreed to vote their founder shares and any public shares purchased during or after the initial public offering,
in favor of our initial business combination. The other members of our management team have entered into a letter agreement similar to
the one entered into by our sponsor with respect to any public shares acquired by them in or after the initial public offering. Additionally,
each public stockholder may elect to redeem its public shares irrespective of whether they vote for or against the proposed transaction.

 

Pursuant to our amended and restated certificate
of incorporation, if we have not completed an initial business combination within 24 months from the closing of the initial public
offering, we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but no more than
ten business days thereafter subject to lawfully available funds therefor, redeem the public shares, at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust
account and not previously released to us to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided
by the number of the then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as
stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly
as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, liquidate
and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other
applicable law. Our sponsor and members of our management team have entered into letter agreements with us, pursuant to which they have
agreed to waive their rights to liquidating distributions from the trust account with respect to their founder shares if we do not complete
an initial business combination within 24 months from the closing of the initial public offering. However, if our sponsor or members
of our management team acquire public shares in or after the initial public offering, they will be entitled to liquidating distributions
from the trust account with respect to such public shares if we do not complete our initial business combination within the prescribed
time period.

 

In the event of a liquidation, dissolution or winding
up of the company after a business combination, our stockholders are entitled to share ratably in all assets remaining available for distribution
to them after payment of liabilities and after provision is made for each class of shares, if any, having preference over the common stock.
Our stockholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the common stock,
except that we will provide our public stockholders with the opportunity to redeem their public shares for cash at a per share price equal
to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not
previously released to us to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number
of the then outstanding public shares, upon the completion of our initial business combination, subject to the limitations described herein.

 

Warrants

 

Each whole warrant entitles the registered holder
to purchase one share of our Class A common stock at a price of $11.50 per share, subject to adjustment as discussed below, at any time
commencing on the later of one year from the closing of the initial public offering and 30 days after the completion of our initial business
combination, provided in each case that we have an effective registration statement under the Securities Act covering the shares of the
Class A common stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or we permit
holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are
registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. Pursuant
to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares of our Class A common stock. This
means only a whole warrant may be exercised at a given time by a warrant holder. No fractional warrants will be issued upon separation
of the units and only whole warrants will trade. Accordingly, unless you purchase at least three units, you will not be able to receive
or trade a whole warrant. The warrants will expire five years after the completion of our initial business combination, at 5:00 p.m.,
New York City time, or earlier upon redemption or liquidation.

 

    3

     

    

 

We will not be obligated to deliver any Class A
common stock pursuant to the exercise of a warrant and will have no obligation to net cash settle such warrant unless a registration statement
under the Securities Act with respect to the shares of our Class A common stock underlying the warrants is then effective and a prospectus
relating thereto is current, subject to our satisfying our obligations described below with respect to registration, or a valid exemption
from registration is available. No warrant will be exercisable and we will not be obligated to issue a share of our Class A common stock
upon exercise of a warrant unless the share of our Class A common stock issuable upon such warrant exercise has been registered, qualified
or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that
the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will
not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In the event that a registration statement
is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for
the unit solely for the share of our Class A common stock underlying such unit.

 

We have agreed that as soon as practicable, but
in no event later than twenty business days after the closing of our initial business combination, we will use our commercially reasonable
efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of our Class A common
stock issuable upon exercise of the warrants. We will use our commercially reasonable efforts to cause the same to become effective and
to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption
of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the issuance of the shares
of our Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the
closing of the initial business combination, warrant holders may, until such time as there is an effective registration statement and
during any period when we will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis”
in accordance with Section 3(a)(9) of the Securities Act or another exemption. In addition, if our Class A common stock is at the time
of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security”
under Section 18(b)(1) of the Securities Act, we may, at our option, require holders of our public warrants who exercise their warrants
to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event we elect to do so,
we will not be required to file or maintain in effect a registration statement, but we will use our best efforts to register or qualify
the shares under applicable blue sky laws to the extent an exemption is not available. In such event, each holder would pay the exercise
price by surrendering the warrants for that number of shares of our Class A common stock equal to the lesser of (A) the quotient obtained
by dividing (x) the product of the number of shares of our Class A common stock underlying the warrants, multiplied by the excess of the
“fair market value” (defined below) less the exercise price of the warrants by (y) the fair market value and (B) 0.361. The
“fair market value” shall mean the volume weighted average price of the shares of our Class A common stock for the ten trading
days ending on the trading day prior to the date on which the notice of exercise is received by the warrant agent.

 

No fractional shares of our Class A common stock
will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional interest in a share, we will round
down to the nearest whole number of the number of shares of our Class A common stock to be issued to the holder. If, at the time of redemption,
the warrants are exercisable for a security other than the shares of our Class A common stock pursuant to the warrant agreement (for instance,
if we are not the surviving company in our initial business combination), the warrants may be exercised for such security. At such time
as the warrants become exercisable for a security other than the shares of our Class A common stock, the Company (or surviving company)
will use its commercially reasonable efforts to register under the Securities Act the security issuable upon the exercise of the warrants.

 

Redemption of Warrants When the Price per Share of Our Class A Common
Stock Equals or Exceeds $18.00

 

Once the warrants become exercisable, we may redeem
the outstanding warrants (except as described herein with respect to the private placement warrants):

 

		●	in whole and not in part;

 

		●	at a price of $0.01 per warrant;

 

		●	upon not less than 30 days’ prior written notice of
redemption to each warrant holder; and

 

		●	if, and only if, the last reported sale price of the shares
of our Class A common stock for any 20 trading days within a 30-trading day period ending three business days before we send to
the notice of redemption to the warrant holders (which we refer to as the “Reference Value”) equals or exceeds $18.00 per
share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like).

 

    4

     

    

 

If and when the warrants become redeemable by us,
we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable
state securities laws. However, we will not redeem the warrants unless an effective registration statement under the Securities Act covering
the shares of our Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those
shares of our Class A common stock is available throughout the 30-day redemption period.

 

We have established the last of the redemption criterion
discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price.
If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled to
exercise his, her or its warrant prior to the scheduled redemption date. Any such exercise would not be done on a “cashless”
basis and would require the exercising warrant holder to pay the exercise price for each warrant being exercised. However, the price of
the shares of our Class A common stock may fall below the $18.00 redemption trigger price (as adjusted for stock splits, stock dividends,
reorganizations, recapitalizations and the like) as well as the $11.50 (for whole shares) warrant exercise price after the redemption
notice is issued.

 

Redemption of Warrants When the Price per Share of Our Class A Common
Stock Equals or Exceeds $10.00

 

Once the warrants become exercisable, we may redeem
the outstanding warrants:

 

		●	in whole and not in part;

 

		●	at $0.10 per warrant upon a minimum of 30 days’ prior
written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and
receive that number of shares determined by reference to the table below, based on the redemption date and the “fair market value”
of our Class A common stock (as defined below);

 

		●	if, and only if, the Reference Value (as defined above under
“Redemption of Warrants When the Price per Share of Our Class A Common Stock Equals or Exceeds $18.00”) equals or exceeds
$10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like); and

 

		●	if the Reference Value is less than $18.00 per share (as
adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) the private placement warrants must also
be concurrently called for redemption on the same terms (except as described above with respect to a holder’s ability to cashless
exercise its warrants) as the outstanding public warrants, as described above.

 

The numbers in the table below represent the number
of shares of our Class A common stock that a warrant holder will receive upon exercise in connection with a redemption by us pursuant
to this redemption feature, based on the “fair market value” of our Class A common stock on the corresponding redemption date
(assuming holders elect to exercise their warrants and such warrants are not redeemed for $0.10 per warrant), determined based on volume-weighted average
price of our Class A common stock as reported during the ten trading days immediately following the date on which the notice of redemption
is sent to the holders of warrants, and the number of months that the corresponding redemption date precedes the expiration date of the
warrants, each as set forth in the table below. We will provide our warrant holders with the final fair market value no later than one
business day after the 10-trading day period described above ends.

 

Pursuant to the warrant agreement, references above
to shares of our Class A common stock shall include a security other than shares of our Class A common stock into which the shares of
our Class A common stock have been converted or exchanged for in the event we are not the surviving company in our initial business combination.
The numbers in the table below will not be adjusted when determining the number of shares of our Class A common stock to be issued upon
exercise of the warrants if we are not the surviving entity following our initial business combination.

 

The stock prices set forth in the column headings
of the table below will be adjusted as of any date on which the number of shares issuable upon exercise of a warrant or the exercise price
is adjusted as set forth under the heading “— Anti-dilution Adjustments” below. If the number of shares issuable
upon exercise of a warrant is adjusted, the adjusted stock prices in the column headings will equal the stock prices immediately prior
to such adjustment, multiplied by a fraction, the numerator of which is the number of shares deliverable upon exercise of a warrant immediately
prior to such adjustment and the denominator of which is the number of shares deliverable upon exercise of a warrant as so adjusted. The
number of shares in the table below shall be adjusted in the same manner and at the same time as the number of shares issuable upon exercise
of a warrant. If the exercise price is adjusted, the adjusted stock prices in the column headings will by multiplied by a fraction, the
numerator of which is the higher of the Market Value and the Newly Issued Price as set forth under the heading “— Anti-dilution Adjustments”
and the denominator of which is $10.00.

 

    5

     

    

 

	Redemption Date
 (period to expiration	 	Fair Market Value of Our Common stock	 
	of warrants)	 	≤$10.00	 	 	$11.00	 	 	$12.00	 	 	$13.00	 	 	$14.00	 	 	$15.00	 	 	$16.00	 	 	$17.00	 	 	≥$18.00	 
	60 months	 	 	0.261	 	 	 	0.281	 	 	 	0.297	 	 	 	0.311	 	 	 	0.324	 	 	 	0.337	 	 	 	0.348	 	 	 	0.358	 	 	 	0.361	 
	57 months	 	 	0.257	 	 	 	0.277	 	 	 	0.294	 	 	 	0.310	 	 	 	0.324	 	 	 	0.337	 	 	 	0.348	 	 	 	0.358	 	 	 	0.361	 
	54 months	 	 	0.252	 	 	 	0.272	 	 	 	0.291	 	 	 	0.307	 	 	 	0.322	 	 	 	0.335	 	 	 	0.347	 	 	 	0.357	 	 	 	0.361	 
	51 months	 	 	0.246	 	 	 	0.268	 	 	 	0.287	 	 	 	0.304	 	 	 	0.320	 	 	 	0.333	 	 	 	0.346	 	 	 	0.357	 	 	 	0.361	 
	48 months	 	 	0.241	 	 	 	0.263	 	 	 	0.283	 	 	 	0.301	 	 	 	0.317	 	 	 	0.332	 	 	 	0.344	 	 	 	0.356	 	 	 	0.361	 
	45 months	 	 	0.235	 	 	 	0.258	 	 	 	0.279	 	 	 	0.298	 	 	 	0.315	 	 	 	0.330	 	 	 	0.343	 	 	 	0.356	 	 	 	0.361	 
	42 months	 	 	0.228	 	 	 	0.252	 	 	 	0.274	 	 	 	0.294	 	 	 	0.312	 	 	 	0.328	 	 	 	0.342	 	 	 	0.355	 	 	 	0.361	 
	39 months	 	 	0.221	 	 	 	0.246	 	 	 	0.269	 	 	 	0.290	 	 	 	0.309	 	 	 	0.325	 	 	 	0.340	 	 	 	0.354	 	 	 	0.361	 
	36 months	 	 	0.213	 	 	 	0.239	 	 	 	0.263	 	 	 	0.285	 	 	 	0.305	 	 	 	0.323	 	 	 	0.339	 	 	 	0.353	 	 	 	0.361	 
	33 months	 	 	0.205	 	 	 	0.232	 	 	 	0.257	 	 	 	0.280	 	 	 	0.301	 	 	 	0.320	 	 	 	0.337	 	 	 	0.352	 	 	 	0.361	 
	30 months	 	 	0.196	 	 	 	0.224	 	 	 	0.250	 	 	 	0.274	 	 	 	0.297	 	 	 	0.316	 	 	 	0.335	 	 	 	0.351	 	 	 	0.361	 
	27 months	 	 	0.185	 	 	 	0.214	 	 	 	0.242	 	 	 	0.268	 	 	 	0.291	 	 	 	0.313	 	 	 	0.332	 	 	 	0.350	 	 	 	0.361	 
	24 months	 	 	0.173	 	 	 	0.204	 	 	 	0.233	 	 	 	0.260	 	 	 	0.285	 	 	 	0.308	 	 	 	0.329	 	 	 	0.348	 	 	 	0.361	 
	21 months	 	 	0.161	 	 	 	0.193	 	 	 	0.223	 	 	 	0.252	 	 	 	0.279	 	 	 	0.304	 	 	 	0.326	 	 	 	0.347	 	 	 	0.361	 
	18 months	 	 	0.146	 	 	 	0.179	 	 	 	0.211	 	 	 	0.242	 	 	 	0.271	 	 	 	0.298	 	 	 	0.322	 	 	 	0.345	 	 	 	0.361	 
	15 months	 	 	0.130	 	 	 	0.164	 	 	 	0.197	 	 	 	0.230	 	 	 	0.262	 	 	 	0.291	 	 	 	0.317	 	 	 	0.342	 	 	 	0.361	 
	12 months	 	 	0.111	 	 	 	0.146	 	 	 	0.181	 	 	 	0.216	 	 	 	0.250	 	 	 	0.282	 	 	 	0.312	 	 	 	0.339	 	 	 	0.361	 
	9 months	 	 	0.090	 	 	 	0.125	 	 	 	0.162	 	 	 	0.199	 	 	 	0.237	 	 	 	0.272	 	 	 	0.305	 	 	 	0.336	 	 	 	0.361	 
	6 months	 	 	0.065	 	 	 	0.099	 	 	 	0.137	 	 	 	0.178	 	 	 	0.219	 	 	 	0.259	 	 	 	0.296	 	 	 	0.331	 	 	 	0.361	 
	3 months	 	 	0.034	 	 	 	0.065	 	 	 	0.104	 	 	 	0.150	 	 	 	0.197	 	 	 	0.243	 	 	 	0.286	 	 	 	0.326	 	 	 	0.361	 
	0 months	 	 	—	 	 	 	—	 	 	 	0.042	 	 	 	0.115	 	 	 	0.179	 	 	 	0.233	 	 	 	0.281	 	 	 	0.323	 	 	 	0.361	 

 

The exact fair market value and redemption date
may not be set forth in the table above, in which case, if the fair market value is between two values in the table or the redemption
date is between two redemption dates in the table, the number of shares of our Class A common stock to be issued for each warrant exercised
will be determined by a straight-line interpolation between the number of shares set forth for the higher and lower fair market values
and the earlier and later redemption dates, as applicable, based on a 365 or 366-day year, as applicable. For example, if the volume-weighted average
price of our Class A common stock as reported during the ten trading days immediately following the date on which the notice of redemption
is sent to the holders of the warrants is $11.00 per share, and at such time there are 57 months until the expiration of the warrants,
holders may choose to, in connection with this redemption feature, exercise their warrants for 0.277 Class A common stock for each whole
warrant. For an example where the exact fair market value and redemption date are not as set forth in the table above, if the volume-weighted average
price of our Class A common stock as reported during the ten trading days immediately following the date on which the notice of redemption
is sent to the holders of the warrants is $13.50 per share, and at such time there are 38 months until the expiration of the warrants,
holders may choose to, in connection with this redemption feature, exercise their warrants for 0.298 Class A common stock for each whole
warrant. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A common stock
per warrant (subject to adjustment).

 

This redemption feature differs from the typical
warrant redemption features used in many other blank check offerings, which typically only provide for a redemption of warrants for cash
(other than the private placement warrants) when the trading price for the shares of our Class A common stock exceeds $18.00 per share
for a specified period of time. This redemption feature is structured to allow for all of the outstanding warrants to be redeemed when
the shares of our Class A common stock are trading at or above $10.00 per share, which may be at a time when the trading price of our
shares of Class A common stock is below the exercise price of the warrants. We have established this redemption feature to provide us
with the flexibility to redeem the warrants without the warrants having to reach the $18.00 per share threshold set forth above under
“— Redemption of Warrants When the Price per Share of Our Class A Common Stock Equals or Exceeds $18.00.” Holders choosing
to exercise their warrants in connection with a redemption pursuant to this feature will, in effect, receive a number of shares for their
warrants based on an option pricing model with a fixed volatility input as of March 18, 2021. This redemption right provides us with an
additional mechanism by which to redeem all of the outstanding warrants, and therefore have certainty as to our capital structure as the
warrants would no longer be outstanding and would have been exercised or redeemed. We will be required to pay the applicable redemption
price to warrant holders if we choose to exercise this redemption right and it will allow us to quickly proceed with a redemption of the
warrants if we determine it is in our best interest to do so. As such, we would redeem the warrants in this manner when we believe it
is in our best interest to update our capital structure to remove the warrants and pay the redemption price to the warrant holders.

 

    6

     

    

 

As stated above, we can redeem the warrants when
the shares of our Class A common stock are trading at a price starting at $10.00, which is below the exercise price of $11.50, because
it will provide certainty with respect to our capital structure and cash position while providing warrant holders with the opportunity
to exercise their warrants on a cashless basis for the applicable number of shares. If we choose to redeem the warrants when the shares
of our Class A common stock are trading at a price below the exercise price of the warrants, this could result in the warrant holders
receiving fewer Class A common stock than they would have received if they had chosen to wait to exercise their warrants for Class A common
stock if and when such Class A common stock were trading at a price higher than the exercise price of $11.50.

 

No fractional shares of our Class A common stock
will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional interest in a share, we will round
down to the nearest whole number of the number of shares of our Class A common stock to be issued to the holder. If, at the time of redemption,
the warrants are exercisable for a security other than the shares of our Class A common stock pursuant to the warrant agreement (for instance,
if we are not the surviving company in our initial business combination), the warrants may be exercised for such security. At such time
as the warrants become exercisable for a security other than the shares of our Class A common stock, the Company (or surviving company)
will use its commercially reasonable efforts to register under the Securities Act the security issuable upon the exercise of the warrants.

 

Redemption Procedures.  A
holder of a warrant may notify us in writing in the event it elects to be subject to a requirement that such holder will not have the
right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person’s
affiliates), to the warrant agent’s actual knowledge, would beneficially own in excess of 4.9% or 9.8% (as specified by the holder)
of the shares of our Class A common stock issued and outstanding immediately after giving effect to such exercise.

 

Anti-dilution Adjustments.  If
the number of outstanding shares of our Class A common stock is increased by a stock capitalization or stock dividend payable in shares
of our Class A common stock, or by a split-up of common stock or other similar event, then, on the effective date of such stock capitalization
or stock dividend, split-up or similar event, the number of shares of our Class A common stock issuable on exercise of each warrant
will be increased in proportion to such increase in the outstanding shares of common stock. A rights offering to holders of common stock
entitling holders to purchase Class A common stock at a price less than the “historical fair market value” (as defined below)
will be deemed a stock dividend of a number of shares of our Class A common stock equal to the product of (i) the number of shares of
our Class A common stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering
that are convertible into or exercisable for Class A common stock) and (ii) one minus the quotient of (x) the price per share of our Class
A common stock paid in such rights offering and (y) the historical fair market value. For these purposes, (i) if the rights offering is
for securities convertible into or exercisable for shares of our Class A common stock, in determining the price payable for Class A common
stock, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise
or conversion and (ii) “historical fair market value” means the volume-weighted average price of shares of our Class
A common stock as reported during the ten trading day period ending on the trading day prior to the first date on which the shares of
our Class A common stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such
rights.

 

    7

     

    

 

In addition, if we, at any time while the warrants
are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to the holders of shares of our
Class A common stock on account of such Class A common stock (or other securities into which the warrants are convertible), other than
(a) as described above, (b) any cash dividends or cash distributions which, when combined on a per share basis with all other cash dividends
and cash distributions paid on the shares of our Class A common stock during the 365-day period ending on the date of declaration
of such dividend or distribution does not exceed $0.50 (as adjusted to appropriately reflect any other adjustments and excluding cash
dividends or cash distributions that resulted in an adjustment to the exercise price or to the number of shares of our Class A common
stock issuable on exercise of each warrant) but only with respect to the amount of the aggregate cash dividends or cash distributions
equal to or less than $0.50 per share, (c) to satisfy the redemption rights of the holders of our Class A common stock in connection with
a proposed initial business combination, (d) to satisfy the redemption rights of the holders of our Class A common stock in connection
with a stockholder vote to amend our amended and restated certificate of incorporation (A) to modify the substance or timing of our obligation
to allow redemption in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our
initial business combination within 24 months from the closing of the initial public offering or (B) with respect to any other provision
relating to stockholders’ rights or pre-initial business combination activity, or (e) in connection with the redemption of
our public shares upon our failure to complete our initial business combination, then the warrant exercise price will be decreased, effective
immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets
paid on each share of our Class A common stock in respect of such event.

 

If the number of outstanding shares of our Class
A common stock is decreased by a consolidation, combination, reverse share split or reclassification of our Class A common stock or other
similar event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or similar event,
the number of shares of our Class A common stock issuable on exercise of each warrant will be decreased in proportion to such decrease
in outstanding shares of our Class A common stock.

 

Whenever the number of shares of our Class A common
stock purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying
the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of shares
of our Class A common stock purchasable upon the exercise of the warrants immediately prior to such adjustment and (y) the denominator
of which will be the number of shares of our Class A common stock so purchasable immediately thereafter.

 

In addition, if (x) we issue additional shares of
our Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of our initial business
combination at an issue price or effective issue price of less than $9.20 per share of our Class A common stock (with such issue price
or effective issue price to be determined in good faith by our board of directors and, in the case of any such issuance to our sponsor
or its affiliates, without taking into account any founder shares held by our initial stockholders or such affiliates, as applicable,
prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than
60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the
completion of our initial business combination (net of redemptions), and (z) the volume-weighted average trading price of our Class
A common stock during the 20 trading day period starting on the trading day prior to the day on which we complete our initial business
combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted
(to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per
share redemption trigger prices described adjacent to “Redemption of Warrants When the Price per Share of Our Class A Common Stock
Equals or Exceeds $18.00” and “Redemption of Warrants When the Price per Share of Our Class A Common Stock Equals or Exceeds
$10.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued
Price, respectively.

 

    8

     

    

 

In case of any reclassification or reorganization
of the outstanding Class A common stock (other than those described above or that solely affects the par value of such Class A common
stock), or in the case of any merger or consolidation of us with or into another corporation (other than a consolidation or merger in
which we are the continuing corporation and that does not result in any reclassification or reorganization of our outstanding Class A
common stock), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of us as an entirety
or substantially as an entirety in connection with which we are dissolved, the holders of the warrants will thereafter have the right
to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the shares of our Class
A common stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount
of our Class A common stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger
or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such
holder had exercised their warrants immediately prior to such event. If less than 70% of the consideration receivable by the holders of
our Class A common stock in such a transaction is payable in the form of our Class A common stock in the successor entity that is listed
for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading
or quoted immediately following such event, and if the registered holder of the warrant properly exercises the warrant within 30 days
following public disclosure of such transaction, the warrant exercise price will be reduced as specified in the warrant agreement based
on the Black-Scholes value (as defined in the warrant agreement) of the warrant. The purpose of such exercise price reduction is
to provide additional value to holders of the warrants when an extraordinary transaction occurs during the exercise period of the warrants
pursuant to which the holders of the warrants otherwise do not receive the full potential value of the warrants.

 

The warrants are issued in registered form under
a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant agreement provides
that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision,
but requires the approval by the holders of at least 65% of the then-outstanding public warrants to make any change that adversely
affects the interests of the registered holders.

 

The warrants may be exercised upon surrender of
the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse
side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless
basis, if applicable), by certified or official bank check payable to us, for the number of warrants being exercised. The warrant holders
do not have the rights or privileges of holders of common stock and any voting rights until they exercise their warrants and receive Class
A common stock. After the issuance of our Class A common stock upon exercise of the warrants, each holder will be entitled to one vote
for each share held of record on all matters to be voted on by stockholders.

 

No fractional shares will be issued upon exercise
of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon
exercise, round down to the nearest whole number, the number of shares of our Class A common stock to be issued to the warrant holder.

 

 

9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]